KRN-5500

DB15215InvestigationalSmall molecule

KRN-5500 is under investigation in clinical trial NCT00002923 (KRN5500 in Treating Patients With Metastatic Solid Tumors).

Chemical structure of KRN-5500
Formula / weight
C28H43N7O7 · 589.694 g/mol (avg)
Code names
KRN-5500 · NSC-650426 · SPK-241

Resolves to

Compound
UNII8VH13L5K20CAS151276-95-8ChEMBLCHEMBL4296683
Structure
InChIKeyLQIPDFIUPOYMPR-BKYURJJWSA-NSMILESCCCCCCCCC\C=C\C=C\C(=O)NCC(=O)N[C@@H]1[C@@H](O)[C@@H](O)[C@@H](NC2=C3N=CNC3=NC=N2)O[C@H]1[C@@H](O)CO

What you can answer from here — as of April 23, 2025

39Drug interactionsStructured to mechanism, not free text
Sign in
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of KRN-5500, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In